A Question of Tolerance—Antigen-Specific Immunotherapy for Type 1 Diabetes | SpringerLink
The rise, fall, and resurgence of immunotherapy in type 1 diabetes - ScienceDirect
Approaches in the Treatment of Type 1 Diabetes Mellitus | EMJ Reviews
How Immunotherapy Could Stop and Prevent Type 1 Diabetes
Diabetology | Free Full-Text | Novel Insights into the Immunotherapy-Based Treatment Strategy for Autoimmune Type 1 Diabetes
Immunotherapy for Type 1 Diabetes – Preclinical and Clinical Trials | IntechOpen
Frontiers | Peptide Immunotherapy for Type 1 Diabetes—Clinical Advances
How Immunotherapy Could Stop and Prevent Type 1 Diabetes
Antigen-specific therapy against Type 1 diabetes: mechanisms and perspectives | Immunotherapy
DNA Immunotherapies for Type 1 Diabetes | IntechOpen
Frontiers | Approaches in Immunotherapy, Regenerative Medicine, and Bioengineering for Type 1 Diabetes
Exploiting novel tailored immunotherapies of type 1 diabetes: Short interfering RNA delivered by cationic liposomes enables efficient down-regulation of variant PTPN22 gene in T lymphocytes - ScienceDirect
The challenge of modulating β-cell autoimmunity in type 1 diabetes - The Lancet Diabetes & Endocrinology
Frontiers | Peptide Immunotherapy for Type 1 Diabetes—Clinical Advances
Collaborative Focused On Immunotherapy In Type 1 Diabetes – ANZ First | ATIC
Surrogate end points in the design of immunotherapy trials: emerging lessons from type 1 diabetes | Nature Reviews Immunology
Imcyse's Type 1 Diabetes Immunotherapy Shows Promise in Phase I
Diabetology | Free Full-Text | Novel Insights into the Immunotherapy-Based Treatment Strategy for Autoimmune Type 1 Diabetes
A Step Toward Diabetes Immunotherapy | Harvard Medical School
Immune Mechanisms and Pathways Targeted in Type 1 Diabetes | SpringerLink
Diabetology | Free Full-Text | Novel Insights into the Immunotherapy-Based Treatment Strategy for Autoimmune Type 1 Diabetes
Immunotherapy in Autoimmune Type 1 Diabetes | The Review of Diabetic Studies
Retraining the immune system to fight type 1 diabetes | Diabetes UK
Immunotherapy of type 1 diabetes: where are we and where should we be going? | Semantic Scholar
Immunotherapy Safe for Diabetes 1? - 2017 - Wiley Analytical Science
A Landmark Trial Establishes The Safety Of Immunotherapy In Type 1 Diabetes
Immunotherapy for Type 1 Diabetes: Why Do Current Protocols Not Halt the Underlying Disease Process? - ScienceDirect
Immune checkpoint inhibitors and type 1 diabetes mellitus: a case report and systematic review in: European Journal of Endocrinology Volume 181 Issue 3 (2019)
